BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 11176943)

  • 1. A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis.
    Pelletier J; Suchet L; Witjas T; Habib M; Guttmann CR; Salamon G; Lyon-Caen O; Chérif AA
    Arch Neurol; 2001 Jan; 58(1):105-11. PubMed ID: 11176943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and magnetic resonance imaging correlates of callosal involvement in multiple sclerosis.
    Pelletier J; Habib M; Lyon-Caen O; Salamon G; Poncet M; Khalil R
    Arch Neurol; 1993 Oct; 50(10):1077-82. PubMed ID: 8215967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interhemispheric transfer in multiple sclerosis. Morphofunctional correlations].
    Pelletier J; Habib M; Brouchon M; Poncet M; Lyon-Caen O; Salamon G; Khalil R
    Rev Neurol (Paris); 1992; 148(11):672-9. PubMed ID: 1303556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study.
    Barkhof FJ; Elton M; Lindeboom J; Tas MW; Schmidt WF; Hommes OR; Polman CH; Kok A; Valk J
    J Neurol; 1998 Mar; 245(3):153-8. PubMed ID: 9553845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voxelwise analysis of conventional magnetic resonance imaging to predict future disability in early relapsing-remitting multiple sclerosis.
    Wybrecht D; Reuter F; Zaaraoui W; Faivre A; Crespy L; Rico A; Malikova I; Confort-Gouny S; Soulier E; Cozzone PJ; Pelletier J; Ranjeva JP; Audoin B
    Mult Scler; 2012 Nov; 18(11):1585-91. PubMed ID: 22454097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corpus callosum index and long-term disability in multiple sclerosis patients.
    Yaldizli O; Atefy R; Gass A; Sturm D; Glassl S; Tettenborn B; Putzki N
    J Neurol; 2010 Aug; 257(8):1256-64. PubMed ID: 20198382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corpus callosum function in verbal dichotic listening: inferences from a longitudinal follow-up of Relapsing-Remitting Multiple Sclerosis patients.
    Gadea M; Marti-Bonmatí L; Arana E; Espert R; Salvador A; Casanova B
    Brain Lang; 2009 Aug; 110(2):101-5. PubMed ID: 19419759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis.
    Wuerfel J; Sinnecker T; Ringelstein EB; Jarius S; Schwindt W; Niendorf T; Paul F; Kleffner I; Dörr J
    Mult Scler; 2012 Nov; 18(11):1592-9. PubMed ID: 22711711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.
    Ge Y; Grossman RI; Udupa JK; Wei L; Mannon LJ; Polansky M; Kolson DL
    Radiology; 2000 Mar; 214(3):665-70. PubMed ID: 10715027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.
    Barone S; Caligiuri ME; Valentino P; Cherubini A; Chiriaco C; Granata A; Filippelli E; Tallarico T; Nisticò R; Quattrone A
    J Neurol; 2018 Oct; 265(10):2243-2250. PubMed ID: 30051273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corpus callosum size correlates with asymmetric performance on a dichotic listening task in healthy aging but not in Alzheimer's disease.
    Gootjes L; Bouma A; Van Strien JW; Van Schijndel R; Barkhof F; Scheltens P
    Neuropsychologia; 2006; 44(2):208-17. PubMed ID: 15955540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ipsilateral silent period: a marker of callosal conduction abnormality in early relapsing-remitting multiple sclerosis?
    Jung P; Beyerle A; Humpich M; Neumann-Haefelin T; Lanfermann H; Ziemann U
    J Neurol Sci; 2006 Dec; 250(1-2):133-9. PubMed ID: 17011585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional connectivity changes and their relationship with clinical disability and white matter integrity in patients with relapsing-remitting multiple sclerosis.
    Sbardella E; Tona F; Petsas N; Upadhyay N; Piattella MC; Filippini N; Prosperini L; Pozzilli C; Pantano P
    Mult Scler; 2015 Nov; 21(13):1681-92. PubMed ID: 26041799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalamic damage and long-term progression of disability in multiple sclerosis.
    Rocca MA; Mesaros S; Pagani E; Sormani MP; Comi G; Filippi M
    Radiology; 2010 Nov; 257(2):463-9. PubMed ID: 20724544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dichotic listening and corpus callosum magnetic resonance imaging in relapsing-remitting multiple sclerosis with emphasis on sex differences.
    Gadea M; Marti-Bonmatí L; Arana E; Espert R; Casanova V; Pascual A
    Neuropsychology; 2002 Apr; 16(2):275-81. PubMed ID: 11949719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study.
    Llufriu S; Blanco Y; Martinez-Heras E; Casanova-Molla J; Gabilondo I; Sepulveda M; Falcon C; Berenguer J; Bargallo N; Villoslada P; Graus F; Valls-Sole J; Saiz A
    PLoS One; 2012; 7(5):e37167. PubMed ID: 22606347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis.
    Achiron A; Barak Y; Rotstein Z
    Mult Scler; 2003 Oct; 9(5):486-91. PubMed ID: 14582775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale.
    Bakshi R; Neema M; Healy BC; Liptak Z; Betensky RA; Buckle GJ; Gauthier SA; Stankiewicz J; Meier D; Egorova S; Arora A; Guss ZD; Glanz B; Khoury SJ; Guttmann CR; Weiner HL
    Arch Neurol; 2008 Nov; 65(11):1449-53. PubMed ID: 19001162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-Defined Corpus Callosal Atrophy in Multiple Sclerosis: A Comparison of Volumetric Measurements, Corpus Callosum Area and Index.
    Granberg T; Bergendal G; Shams S; Aspelin P; Kristoffersen-Wiberg M; Fredrikson S; Martola J
    J Neuroimaging; 2015; 25(6):996-1001. PubMed ID: 25786805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.